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A b s t r a c t: Pulmonary embolism (PE) is the fourth cause of pleural effusions, 
after pneumonia, neoinfiltrates and tuberculosis. Several questions are yet unanswered: 
are the pleural effusions in PE exudates or transudates, what is their size, are they 
unilateral or bilateral, are they only haemorrhagic, etc. 
The aim of this study is to determine the frequency, side, size, biochemical and 
cytological characteristics of pleural effusions in PE.  
In this study, 100 patients with suspicion of PE were examined and treated and 
in all the diagnosis of PE was establish. 31 of them had pleural effusions. 
Of 31 patients with PE and pleural effusions, six (9.84%), had bilateral pleural 
effusions, 14 (22.95%) patients had right-sided pleural effusion, and 11 (18.03%) had 
pleural effusion on the left side. 22 (36.07%) had small pleural effusions, 8 (13.11%) 
had medium and 1 (1.64%) had a large pleural effusion.18 (29.51%) had yellowish 
colored pleural effusions, 12 (19.67%) had haemorrhagic pleural effusions and 1 
(1.64%) had transparent pleural effusion. Values of the total protein in pleural effusions 
varied in the interval 45.70 ± 7.25 gr/l., 30 patients had LDH an effusion/sera ratio 
bigger than 0.6, and 1 patient had an LDH p/s ratio < 0.6. 15 patients (24.59) had neu-
trophil cells, 10 (16.39%) had lymphocytes, and eosinophil cells dominated in 5 
(8.20%). One patient (1.64%) had a negative cytological finding. 
We can conclude that pleural effusions secondary to PE can be found in around 
one third of all cases with PE. They are small, mostly unilateral, often but not always 
haemorrhagic. They are always exudates with a predomination of neutrofil cells.  
Key words: pulmonary embolism, pleural effusion, unilateral, exudates, neutrofil.  
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Introduction 
 
Pulmonary embolism (PE) is a disorder with significant rate of mor-
bidity and mortality. Therefore, it is of great importance to improve diagnosis of 
PE. PE is the fourth cause of pleural effusions, after pneumonia, neoinfiltrates 
and tuberculosis [1].  
It is estimated that frequency of pleural effusions due to PE is to be 
found in 30–50% of patients with PE [2], but in some studies they occur in less 
than 5% of all cases with PE. This is probably because PE is not considered in 
patients with undiagnosed pleural effusions and because thoracocenthesis is not 
performed on these patients [3]. Also, the biochemical characteristics of pleural 
effusions in PE were not examined, so that they were classified as exudates or 
transudates [5] and rarely haemorrhagic [6].  
The exact pathophisiological mechanism in forming the pleural effusion 
in PE remains unknown. It seems that the embolus in the peripheral pulmonary 
arteries is the reason for mesothelial reaction and releasing cytokines that 
increase the permeability of the vessels and when the lymph vessels exceed 
their capacity to eliminate the liquid from the pleural space pleural effusion is 
created [6]. Anther mechanism for forming the pleural effusion seems to be 
increased systemic venous pressure in the parietal pleura because of pulmonary 
hypertension and right heart failure that leads to having transudates in PE [5]. 
But pulmonary hypertension is often not so serious in patients with PE as to 
create right heart failure. In fact it is assumed that most of the trasudates in PE 
are the result of undiagnosed congestive heart disease [7]. 
Several questions are still unanswered: are the pleural effusions in PE 
exudates or transudates, what is their size, are they unilateral or bilateral, are 
they only haemorrhagic, etc.  
 
 
Aim of the study 
 
The aim of this study is to determine the frequency, side, size, bio-
chemical and cytological characteristics of pleural effusions in PE.  
 
 
Material and Methods 
 
In this study, 100 patients with suspicion of PE were examined and 
treated in the Lung Diseases and Tuberculosis Institute, Skopje, R. Macedonia 
in the period from May 2006 to December 2011 and in all the diagnosis of PE 
was establish. Thirty-one of them had pleural effusions. 
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As a control group we enrolled 100 patients who were treated fot 
COPD, pneumonias, chronic cardiomyopathy and other pulmonary diseases and 
in all of them PE was excluded. In this group 30 patients also had pleural 
effusions.  
Standard diagnostic procedures were performed on all patients: 
Standard laboratory analyses (ESR, CBC, AST, ALT, urea, creatinine 
level, electrolyte status, protein status:  
CXR with profile;  
Blood gas analysis (AVL Compaq 3 blood gas analyser);  
Clinical decision rule (Wells score); 
D-dimmer levels (Latex agglutination quantitative method INNO-
VANCE D-dimmer, Siemens, Germany) range 170–4500 ng/ml. D-dimmer levels 
above 500 ng/ml, were abnormal), MDCT angiography, V/Q study; 
In patients with pleural effusions the following were performed: 
Chest ultrasound (CUS) (ALOKA SSD 1100 with convex probe 3,5 
MHz and linear probe 7.5 MHz), thoracocentesis, biochemical and cytological 
analysis of the pleural effusions (total protein level, LDH level, total protein 
level ratio in pleural fluid and sera, LDH level ratio in pleural fluid and sera) 
 
Statistical analysis 
Differences of analysed parameters in series with attributive values 
were tested with Pearson Chi-square (x2); in series with numeric attributes des-
criptive statistic was used (Mean ± Std. Dev., ± 95,00 CI., minimal and maxi-
mal value); in series with numerical values, differences between two indepen-
dent samples were tested with the Mann-Whitney U test (U/Z). 
 
 
Results 
 
In the study group with PE, 31 patients (31%) had pleural effusion.  
Thirty patients (30%) in the control group also had pleural effusion 
(Table 1). The distribution data for the pleural effusion showed that there was 
no statistical difference between the study and the control groups for χ2 = 0.02 
and p > 0.05 (p = 0.88). 
Of the 31 patients with PE and pleural effusions, six (9.84%), had 
bilateral pleural effusion, 14 (22.95%) patients had righ-sided pleural effusion, 
and 11 (18.03%) had pleural effusion on the left side. In the control group all 
patients had bilateral pleural effusions (49.18%). The distribution data for the 
pleural effusion sides showed that there is a significant statistical difference 
between the study and the control group of χ2 = 40.99 and p < 0.001 (Table 2). 
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Table 1 
 
Pleural effusions/study and control group 
Pearson Chi-square: 0.02, df = 1, p = 0.88 
 Group Pl. effusion 
absent 
Pl. effusion 
present 
Row 
Totals 
Count Study 69 31 100 
Total Percent  69.00% 31.00% 100.00% 
Count Control 70 30 100 
Total Percent  70.00% 30.00% 100.00% 
Count All Grps 139 61 200 
 
Table 2     
 
Side of pleural effusions 
Pearson Chi-square: 40.99, df = 2, p = 0.000 
 Group Bilateral Right Left Row Totals 
Count Study 6 14 11 31 
Total Percent  9.84% 22.95% 18.03% 50.82% 
Count Control 30 0 0 30 
Total Percent  49.18% 0.00% 0.00% 49.18% 
Count All Grps 36 14 11 61 
Total Percent  59.02% 22.95% 18.03%  
 
Of the 31 patients with pleural effusion, 22 (36.07%) had small pleural 
effusions, 8 (13.11%) had medium and 1 (1.64%) had a large pleural effusion. 
Of the 30 patients in the control group, six (9.84%) had small, 14 (22.95%) had 
medium and 10 (16.39%) had large pleural effusions. Distribution data for the 
size of the pleural effusion showed that there is a significant statistical diffe-
rence between the study and the control groups of χ2 = 18.13 and p < 0.001 
(Table 3). 
In the study group, 18 (29.51%) had yellowish pleural effusions, 12 
(19.67%) had haemorrhagic pleural effusion and 1 (1.64%) had a transparent 
pleural effusion. Of the 30 patients in the control group, 11 (18.03%) had yel-
low, 7 (11.48%) had haemorrhagic pleural effusions and 12 (19.67%) had 
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transparent pleural effusions. Distribution data for the colour of the pleural 
effusion showed that there is a significant statistical difference between the 
study and the control group of χ2 = 12.30 and p < 0.01 (p = 0.002) (Table 4). 
 
Table 3      
 
Size of pleural effusions 
Pearson Chi-square: 18.13, df = 2, p = 0.000 
 Group Small Medium Large Row Totals 
Count Study 22 8 1 31 
Total Percent  36.07% 13.11% 1.64% 50.82% 
Count Control 6 14 10 30 
Total Percent  9.84% 22.95% 16.39% 49.18% 
Count All Grps 28 22 11 61 
Total Percent  45.90% 36.07% 18.03%  
 
Table 4     
 
Colour of pleural effusions 
Pearson Chi-square: 12.30, df = 2, p = 0.002 
 Group Yellowish Haemorr. Clear Row Totals 
Count Study 18 12 1 31 
Total Percent  29.51% 19.67% 1.64% 50.82% 
Count Control 11 7 12 30 
Total Percent  18.03% 11.48% 19.67% 49.18% 
Count All Grps 29 19 13 61 
Total Percent  47.54% 31.15% 21.31%  
 
In the study group (Fig. 1), values of the total protein in pleural effu-
sions vary in the interval 45.70 ± 7.25 gr/l., ± 95.00% CI: 43,04–48.36; the mini-
mal value is 21.10 g/l., and the maximal value is 58.10 g/l. Total proteins in 
effusions in the control group vary in the interval 23.12 ± 7.01 gr./l., ± 95.00% 
CI: 20,51–25.74; the minimal value is 00.00 g/l., and maximal value 32.0 g/l. 
(Table 5).  
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Figure 1 – Values of the total protein in pleural effusions 
 
Table 5 
 
Total proteins in pleural effusions/study and control group 
Total proteins/ 
group 
Valid 
N 
Mean 
Confidence
-95.00% 
Confidence 
+95.00% Min Max Std. Dev 
Study 31 45.70 43.04 48.36 21.10 58.10 7.25 
Control 30 23.12 20.51 25.74 0.00 32.00 7.01 
 
Mean values of the total proteins in pleural effusion in the study group 
are bigger than in the control group, Z = 6.46 and p < 0.001; the difference is 
significant (Table 6). 
 
Table 6 
 
Total proteins in pleural effusions/ differences 
Rank Sum 
Study group 
Rank Sum 
Control group U Z p-level Total 
proteins 
1409.00 482.00 17.00 6.46 0.000 
 
In the study group, 30 patients had an LDH effusion/sera ratio greater 
than 0.6, and 1 patient had the LDH p/s ratio < 0.6. In the control group none of 
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them had LDH > 0.6. Distribution data for the LDH ratio p/s > 0.6 showed that 
there is a significant statistical difference between the study and the control 
groups, χ2 = 57.13 and p < 0.001 (Table 7). 
 
Table 7 
 
LDH ratio p/s in study and control group 
Pearson Chi-square: 57.13, df = 1, p = 0.000 
 Group LDH p/s > 0.6 YES 
LDH p/s 
> 0.6 NO 
Row 
Totals 
Count Study 30 1 31 
Total Percent  49.18% 1.64% 50.82% 
Count Control 0 30 30 
Total Percent  0.00% 49.18% 49.18% 
Count All Grps 30 31 61 
Total Percent  49.18% 50.82% 
 
In the study group, 15 patients (24.59) had neutrophil cells, 10 had 
lymphocytes (16.39%), and eosinophil cells dominated in 5 (8.20%). One pati-
ent (1.64%) had a negative cytological finding. In the control group all 30 pati-
ents had negative cytological findings. Distribution data for the cytological 
findings in the pleural effusions showed that there is a significant statistical dif-
ference between the study and the control group, χ2 = 57,13 and p < 0.001 
(Table 8). 
 
Table 8 
 
Cytological characteristics of pleural effusions 
Pearson Chi-square: 57.13, df = 3, p = 0.000 
Cytology 
 Group 
No Lympho Eo Neutro 
Row 
Totals 
Count Study 1 10 5 15 31 
Total Percent 1.64% 16.39% 8.20% 24.59% 50.82% 
Count Control 30 0 0 0 30 
Total Percent 49.18% 0.00% 0.00% 0.00% 49.18% 
Count All Grps 31 10 5 15 61 
Total Percent 50.82% 16.39% 8.20% 24.59%  
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Discussion 
 
In the literature, the incidence of pleural effusions in PE varies between 
23 and 48%, diagnosed with chest radiography [8, 9]. Data for pleural effusions 
described with MDCT are partial because there is still a relatively small series 
of patients with that pathology. In several studies pleural effusions due to PE 
are described as transudative or exudative, although in recent years almost all 
studies reject this hypothesis [10, 3]. In our study 31% with PE had pleural effu-
sions; this data is compatable with the data published by several authors [8, 9]. 
In the study several aspects of the pleural effusions in PE (study group) 
and pleural effusion due to other conditions (control group) were examined. 
CUS was performed to diagnose pleural effusion; thoracocenthesis under CUS 
was performed in every effusion greater than 1 cm., every pleural effusion was 
macroscopically (colour), microscopically, biochemically and cytologically exa-
mined. 
There is a statistically significant difference for the side of pleural 
effusion between the study and the control group of χ2 = 40.99 and p < 0.001; in 
this study pleural effusions in PE are unilateral. This data matches the data of 
Pocel et al. [11].  
It is caractersitic that pleural effusion which are small dominate in our 
study, and there is a statistically significant difference between the study and the 
control group of χ2 = 18.13 and p < 0.001; these data are very similar to those of 
Porcel et al., Candeira et al. and Light et al. [11, 3, 10]. 
Although many thought that pleural effusions in PE are mostly haemor-
ragic, still many studies, especially that of of Candeira et al. [3], show that the 
colous of the plural effusion varies from yellowish to haemorrhagic. In our 
study, yellowish colour of the pleural effusions dominated in PE (29.5%), with 
haemorrhagic (19.67%). There is a signicifant difference between the study and 
the control group of χ2 = 12.30 and p < 0,01 (p = 0.002).  
This study showes the uniformity of the exudative character of the 
pleural effusions in PE. Until 1976, most authors classified the pleural effusions 
as exudates [12–15]. But Bynum and Wilson [4] in 1976 published a study in 
which one third of 26 pleural effusions in PE were transudates. This paper is 
cited many times, but there were no attempts to compare these data with data 
from other authors. The pape, however, also has several methodological restric-
tions; effusions are obtained with rigid thoracothomy which can alter the cha-
racter of the effusion; a small group of patients was examined, outdated bioche-
mical criteria for the exudative character of effusion were used; total protein 
levels and LDH levels in pleural effusion were not examined. In our study, the 
mean value of the total proteins is 45.7 g/l; all the pleural effusions in PE are 
exudates, and the total protein ratio in pleural effusions/sera is > 0.5. The mean 
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values of the total proteins in pleural effusions in the patients in the study group 
are greater than in the patients in the control group, Z = 6.46 and p < 0.001, and 
there is a significant difference. Also, there is a significant difference between 
LDH levels in pleural effusions in the study and the control groups, χ2 = 57.13 
and p < 0.001. These values show that pleural effusions are exudates according 
to the Light LW criteria [10, 5].  
In the present study, neutrophil cells dominate in the pleural effuions 
due to PE (in almost half the pleural effusions). These data match the data from 
Light LW [16] and, partially, the results from Porcel et al., Candeira SR et al. 
[11, 3].  
 
 
Conclusion 
 
In this study we have shown that pleural effusions secondary to pul-
monary embolism can be found in around one third of all cases with PE. They 
are small, mostly unilateral, often, but not always, haemorrhagic. They are 
always exudates with a predomination of neutrofil cells.  
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R e z i m e  
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Belodrobnata tromboembolija (BE) e ~etvrta pri~ina za pojava na 
plevralen izliv, po pnevmonii, maligni bolesti i tuberkuloza. S# u{te 
postojat nekolku neodgovoreni pra{awa: dali plevralnite izlivi kaj BE 
se transudati ili eksudati, kakva e nivnata golemina, dali se unilateralni 
ili bilateralni, dali se hemoragi~ni itn.  
Celta na studijata e da se odredi frekвencijata, stranata, golemi-
nata, biohemiskite i citolo{kite karakteristiki na plevralnite izlivi 
kaj BE. 
Vo studijata ispitani se 100 pacienti suspektni za postoewe na BE. 
Kaj site e potvrdena dijagnoza za BE, a plevralni izlivi imaa 31 pacient.  
Od 31 pacient so BE i plevralni izlivi: {est (9,84%) imaa bila-
teralni plevralni izlivi, 14 (22,95%) pacienti imaa desnostran plevralen 
izliv, i 11 (18,03%) imaa plevralen izliv od levata strana. 22 (36,07%) 
imaa mali plevralni izlivi, 8 (13,11%) imaa sredni i 1 (1,64%) ima{e 
masiven plevralen izliv. Kaj 18 (29,51%) plevralniot izliv be{e so `olta 
boja, 12 (19,67%) imaa hemoragi~en, a eden (1,64%) ima{e bezboen plevra-
len izliv.  
Vrednostite na vkupnite proteini vo plevralnite izlivi variraa 
vo intervali 45,70 ± 7,25 gr/l. 30 pacienti imaa LDH odnos na punktat/serum 
pogolem od 0,6, i 1 pacient ima{e LDH odnos na punktat/serum pomal od 0,6. 
Kaj 15 pacienti (24,59) dominiraa neutrofili vo plevralnata te~nost, 
limfociti imaa 10 (16,39%), i eozinofili ima{e kaj 5 (8,20%). Eden paci-
ent ima{e negativen citolo{ki naod. 
Mo`eme da zaklu~ime deka plevralnite izlivi poradi BE mo`e da 
se sretnat kaj okolu edna tretina od pacientite so BE. Tie se mali, naj-
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~esto ednostrani, ~esto no ne sekoga{ hemoragi~ni. Sekoga{ se eksudati so 
predominacija na neutrofili.  
 
Klu~ni zborovi: belodrobna tromboembolija, plevralen izliv, ednostran, 
eksudati, neutrofili.  
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